Literature DB >> 33767450

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.

Selina Jansky1,2,3, Ashwini Kumar Sharma4, Verena Körber5, Andrés Quintero3,4, Umut H Toprak1,2, Elisa M Wecht1,2, Moritz Gartlgruber1,2, Alessandro Greco3,5, Elad Chomsky6, Thomas G P Grünewald1,7,8, Kai-Oliver Henrich1,2, Amos Tanay6, Carl Herrmann4, Thomas Höfer5, Frank Westermann9,10.   

Abstract

Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. However, the cellular origin of neuroblastoma has yet to be defined. Here we studied the single-cell transcriptomes of neuroblastomas and normal human developing adrenal glands at various stages of embryonic and fetal development. We defined normal differentiation trajectories from Schwann cell precursors over intermediate states to neuroblasts or chromaffin cells and showed that neuroblastomas transcriptionally resemble normal fetal adrenal neuroblasts. Importantly, neuroblastomas with varying clinical phenotypes matched different temporal states along normal neuroblast differentiation trajectories, with the degree of differentiation corresponding to clinical prognosis. Our work highlights the roles of oncogenic MYCN and loss of TFAP2B in blocking differentiation and may provide the basis for designing therapeutic interventions to overcome differentiation blocks.

Entities:  

Mesh:

Year:  2021        PMID: 33767450     DOI: 10.1038/s41588-021-00806-1

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  73 in total

1.  Telomerase activation by genomic rearrangements in high-risk neuroblastoma.

Authors:  Martin Peifer; Falk Hertwig; Frederik Roels; Daniel Dreidax; Moritz Gartlgruber; Roopika Menon; Andrea Krämer; Justin L Roncaioli; Frederik Sand; Johannes M Heuckmann; Fakhera Ikram; Rene Schmidt; Sandra Ackermann; Anne Engesser; Yvonne Kahlert; Wenzel Vogel; Janine Altmüller; Peter Nürnberg; Jean Thierry-Mieg; Danielle Thierry-Mieg; Aruljothi Mariappan; Stefanie Heynck; Erika Mariotti; Kai-Oliver Henrich; Christian Gloeckner; Graziella Bosco; Ivo Leuschner; Michal R Schweiger; Larissa Savelyeva; Simon C Watkins; Chunxuan Shao; Emma Bell; Thomas Höfer; Viktor Achter; Ulrich Lang; Jessica Theissen; Ruth Volland; Maral Saadati; Angelika Eggert; Bram de Wilde; Frank Berthold; Zhiyu Peng; Chen Zhao; Leming Shi; Monika Ortmann; Reinhard Büttner; Sven Perner; Barbara Hero; Alexander Schramm; Johannes H Schulte; Carl Herrmann; Roderick J O'Sullivan; Frank Westermann; Roman K Thomas; Matthias Fischer
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

2.  Neuroblastoma is composed of two super-enhancer-associated differentiation states.

Authors:  Tim van Groningen; Jan Koster; Linda J Valentijn; Danny A Zwijnenburg; Nurdan Akogul; Nancy E Hasselt; Marloes Broekmans; Franciska Haneveld; Natalia E Nowakowska; Johannes Bras; Carel J M van Noesel; Aldo Jongejan; Antoine H van Kampen; Linda Koster; Frank Baas; Lianne van Dijk-Kerkhoven; Margriet Huizer-Smit; Maria C Lecca; Alvin Chan; Arjan Lakeman; Piet Molenaar; Richard Volckmann; Ellen M Westerhout; Mohamed Hamdi; Peter G van Sluis; Marli E Ebus; Jan J Molenaar; Godelieve A Tytgat; Bart A Westerman; Johan van Nes; Rogier Versteeg
Journal:  Nat Genet       Date:  2017-06-26       Impact factor: 38.330

3.  A mechanistic classification of clinical phenotypes in neuroblastoma.

Authors:  Sandra Ackermann; Maria Cartolano; Barbara Hero; Anne Welte; Yvonne Kahlert; Andrea Roderwieser; Christoph Bartenhagen; Esther Walter; Judith Gecht; Laura Kerschke; Ruth Volland; Roopika Menon; Johannes M Heuckmann; Moritz Gartlgruber; Sabine Hartlieb; Kai-Oliver Henrich; Konstantin Okonechnikov; Janine Altmüller; Peter Nürnberg; Steve Lefever; Bram de Wilde; Frederik Sand; Fakhera Ikram; Carolina Rosswog; Janina Fischer; Jessica Theissen; Falk Hertwig; Aatur D Singhi; Thorsten Simon; Wenzel Vogel; Sven Perner; Barbara Krug; Matthias Schmidt; Sven Rahmann; Viktor Achter; Ulrich Lang; Christian Vokuhl; Monika Ortmann; Reinhard Büttner; Angelika Eggert; Frank Speleman; Roderick J O'Sullivan; Roman K Thomas; Frank Berthold; Jo Vandesompele; Alexander Schramm; Frank Westermann; Johannes H Schulte; Martin Peifer; Matthias Fischer
Journal:  Science       Date:  2018-12-07       Impact factor: 47.728

4.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

5.  Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage.

Authors:  D J Anderson; J F Carnahan; A Michelsohn; P H Patterson
Journal:  J Neurosci       Date:  1991-11       Impact factor: 6.167

6.  Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.

Authors:  Isabelle Janoueix-Lerosey; Delphine Lequin; Laurence Brugières; Agnès Ribeiro; Loïc de Pontual; Valérie Combaret; Virginie Raynal; Alain Puisieux; Gudrun Schleiermacher; Gaëlle Pierron; Dominique Valteau-Couanet; Thierry Frebourg; Jean Michon; Stanislas Lyonnet; Jeanne Amiel; Olivier Delattre
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

Review 7.  Neuroblastoma.

Authors:  John M Maris; Michael D Hogarty; Rochelle Bagatell; Susan L Cohn
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

8.  Identification of ALK as a major familial neuroblastoma predisposition gene.

Authors:  Yaël P Mossé; Marci Laudenslager; Luca Longo; Kristina A Cole; Andrew Wood; Edward F Attiyeh; Michael J Laquaglia; Rachel Sennett; Jill E Lynch; Patrizia Perri; Geneviève Laureys; Frank Speleman; Cecilia Kim; Cuiping Hou; Hakon Hakonarson; Ali Torkamani; Nicholas J Schork; Garrett M Brodeur; Gian P Tonini; Eric Rappaport; Marcella Devoto; John M Maris
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

9.  Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.

Authors:  Valentina Boeva; Caroline Louis-Brennetot; Agathe Peltier; Simon Durand; Cécile Pierre-Eugène; Virginie Raynal; Heather C Etchevers; Sophie Thomas; Alban Lermine; Estelle Daudigeos-Dubus; Birgit Geoerger; Martin F Orth; Thomas G P Grünewald; Elise Diaz; Bertrand Ducos; Didier Surdez; Angel M Carcaboso; Irina Medvedeva; Thomas Deller; Valérie Combaret; Eve Lapouble; Gaelle Pierron; Sandrine Grossetête-Lalami; Sylvain Baulande; Gudrun Schleiermacher; Emmanuel Barillot; Hermann Rohrer; Olivier Delattre; Isabelle Janoueix-Lerosey
Journal:  Nat Genet       Date:  2017-07-24       Impact factor: 38.330

10.  Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.

Authors:  Katleen De Preter; Jo Vandesompele; Pierre Heimann; Nurten Yigit; Siv Beckman; Alexander Schramm; Angelika Eggert; Raymond L Stallings; Yves Benoit; Marleen Renard; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

View more
  37 in total

1.  Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.

Authors:  Nathaniel W Mabe; Min Huang; Guillermo N Dalton; Gabriela Alexe; Daniel A Schaefer; Anna C Geraghty; Amanda L Robichaud; Amy S Conway; Delan Khalid; Marius M Mader; Julia A Belk; Kenneth N Ross; Michal Sheffer; Miles H Linde; Nghi Ly; Winnie Yao; Maria Caterina Rotiroti; Benjamin A H Smith; Marius Wernig; Carolyn R Bertozzi; Michelle Monje; Constantine S Mitsiades; Ravindra Majeti; Ansuman T Satpathy; Kimberly Stegmaier; Robbie G Majzner
Journal:  Nat Cancer       Date:  2022-07-11

2.  Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.

Authors:  Xiyuan Zhang; Hannah E Lou; Vishaka Gopalan; Zhihui Liu; Hilda M Jafarah; Haiyan Lei; Paige Jones; Carly M Sayers; Marielle E Yohe; Prashant Chittiboina; Brigitte C Widemann; Carol J Thiele; Michael C Kelly; Sridhar Hannenhalli; Jack F Shern
Journal:  Cell Rep       Date:  2022-09-20       Impact factor: 9.995

3.  Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes.

Authors:  Satyaki Sengupta; Sanjukta Das; Angela C Crespo; Annelisa M Cornel; Anand G Patel; Navin R Mahadevan; Marco Campisi; Alaa K Ali; Bandana Sharma; Jared H Rowe; Hao Huang; David N Debruyne; Esther D Cerda; Malgorzata Krajewska; Ruben Dries; Minyue Chen; Shupei Zhang; Luigi Soriano; Malkiel A Cohen; Rogier Versteeg; Rudolf Jaenisch; Stefani Spranger; Rizwan Romee; Brian C Miller; David A Barbie; Stefan Nierkens; Michael A Dyer; Judy Lieberman; Rani E George
Journal:  Nat Cancer       Date:  2022-09-22

4.  RNA velocity unraveled.

Authors:  Gennady Gorin; Meichen Fang; Tara Chari; Lior Pachter
Journal:  PLoS Comput Biol       Date:  2022-09-12       Impact factor: 4.779

5.  Serotonin limits generation of chromaffin cells during adrenal organ development.

Authors:  Polina Kameneva; Victoria I Melnikova; Maria Eleni Kastriti; Anastasia Kurtova; Emil Kryukov; Aliia Murtazina; Louis Faure; Irina Poverennaya; Artem V Artemov; Tatiana S Kalinina; Nikita V Kudryashov; Michael Bader; Jan Skoda; Petr Chlapek; Lucie Curylova; Lukas Sourada; Jakub Neradil; Marketa Tesarova; Massimo Pasqualetti; Patricia Gaspar; Vasily D Yakushov; Boris I Sheftel; Tomas Zikmund; Jozef Kaiser; Kaj Fried; Natalia Alenina; Elena E Voronezhskaya; Igor Adameyko
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

Review 6.  Advancing therapy for neuroblastoma.

Authors:  Bo Qiu; Katherine K Matthay
Journal:  Nat Rev Clin Oncol       Date:  2022-05-25       Impact factor: 65.011

7.  BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells.

Authors:  Jessica Sriha; Caroline Louis-Brennetot; Cécile Pierre-Eugène; Sylvain Baulande; Virginie Raynal; Amira Kramdi; Igor Adameyko; Uwe Ernsberger; Thomas Deller; Olivier Delattre; Isabelle Janoueix-Lerosey; Hermann Rohrer
Journal:  Cancers (Basel)       Date:  2022-06-01       Impact factor: 6.575

8.  Linking human sympathoadrenal development and neuroblastoma.

Authors:  Hermann Rohrer
Journal:  Nat Genet       Date:  2021-05       Impact factor: 38.330

Review 9.  Bone Marrow Environment in Metastatic Neuroblastoma.

Authors:  Chiara Brignole; Fabio Pastorino; Patrizia Perri; Loredana Amoroso; Veronica Bensa; Enzo Calarco; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

Review 10.  Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?

Authors:  Kiyohiro Ando; Akira Nakagawara
Journal:  Biomolecules       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.